The Enterprise Value as of September 2024 (TTM) for Sigilon Therapeutics, Inc. (SGTX) is 43.98M

According to Sigilon Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 43.98M. This represents a change of -77.00% compared to the average of 191.27M of the last 4 quarters.

Sigilon Therapeutics, Inc. (SGTX) Historical Enterprise Value (quarterly & annually)

How has SGTX Enterprise Value performed in the past?

The mean historical Enterprise Value of Sigilon Therapeutics, Inc. over the last ten years is 532.34M. The current 43.98M Enterprise Value has changed 726.25% with respect to the historical average. Over the past ten years (40 quarters), SGTX's Enterprise Value was at its highest in in the December 2020 quarter at 8.10B. The Enterprise Value was at its lowest in in the December 2019 quarter at -51015000.00.

Sigilon Therapeutics, Inc. (SGTX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Sigilon Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Sigilon Therapeutics, Inc. (SGTX) Average Enterprise Value

How has SGTX Enterprise Value performed in the past?

The current Enterprise Value of Sigilon Therapeutics, Inc. (SGTX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Sigilon Therapeutics, Inc. (SGTX) Enterprise Value vs. Peers

How is SGTX’s Enterprise Value compared to its peers?

Sigilon Therapeutics, Inc.’s Enterprise Value is greater than Reviva Pharmaceuticals Holdings, Inc. (33.47M), greater than ZyVersa Therapeutics, Inc. (2.41M), greater than Kiromic BioPharma, Inc. (11.97M), greater than Unicycive Therapeutics, Inc. (40.56M), less than Oncorus, Inc. (51.18M), greater than eFFECTOR Therapeutics, Inc. (3.86M), greater than Apollomics, Inc. (-6854900.00), greater than Angion Biomedica Corp. (22.43M), greater than Cardio Diagnostics Holdings, Inc. (6.34M), greater than Sonnet BioTherapeutics Holdings, Inc. (1.11M), less than X4 Pharmaceuticals, Inc. (51.37M), greater than Landos Biopharma, Inc. (42.62M), greater than Apexigen, Inc. (205.32K), greater than Navidea Biopharmaceuticals, Inc. (-2504975.00), greater than NovaBay Pharmaceuticals, Inc. (3.62M), greater than InMed Pharmaceuticals Inc. (-4282240.00), greater than GeoVax Labs, Inc. (21.51M), greater than Phio Pharmaceuticals Corp. (-1943693.00),

Build a custom stock screener for Sigilon Therapeutics, Inc. (SGTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sigilon Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Sigilon Therapeutics, Inc. (SGTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Sigilon Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.